Background illustration for clinical trials search

Paid Clinical Trials Norman

Discover 568 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Oklahoma City OK, Salina KS, Hays KS, Topeka KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

for
Advanced Alveolar Soft Part Sarcoma,
Location: Oklahoma City OK, Houston TX, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05333458

Phase2, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Oklahoma City OK, Dallas TX, Fort Worth TX, Tyler TX,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase1, Phase2, Recruiting

The Effect of NAD Supplementation on Brain Vascular Health in Aging

for
Aging
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 60 - 70+

Code: NCT05483465

Recruiting

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

for
Sickle Cell Disease
Location: Oklahoma City OK, Little Rock AR, Houston TX,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 12+

Code: NCT06612268

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

for
Thrombotic Thrombocytopenic Purpura,
Location: Oklahoma City OK
Sponsor: Insel Gruppe AG, University Hospital Bern

Sex: All

Age: 0+

Code: NCT01257269

Recruiting

The Effect of Different Low-Level Tragus Stimulation Parameters On Autonomic Nervous System Function

for
Atrial Fibrillation, Heart Failure, Diastolic
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 21 - 70+

Code: NCT04682704

Recruiting

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

for
Laceration of Skin, Anxiety, Discharge Time
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 1 - 5

Code: NCT05934669

Recruiting

Combination of TATE and PD-1 Inhibitor in Liver Cancer

for
Hepatocellular Carcinoma, Gastric Cancer
Location: Oklahoma City OK, Milwaukee WI, Orange CA
Sponsor: Teclison Ltd.

Sex: All

Age: 18 - 70+

Code: NCT03259867

Phase2, Recruiting

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

for
Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection,
Location: Oklahoma City OK, Little Rock AR, Houston TX,
Sponsor: University of Calgary

Sex: All

Age: 0 - 21

Code: NCT05219110

Recruiting

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Oklahoma City OK, Springfield MO, Little Rock AR,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06500481

Phase3, Recruiting

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

for
Metastatic Malignant Solid Neoplasm,
Location: Oklahoma City OK, Madison WI, Chicago IL, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687110

Phase1, Recruiting

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Oklahoma City OK, Lewisville TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06585410

Phase3, Recruiting

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

for
Focal Segmental Glomerulosclerosis, Minimal Change Disease,
Location: Oklahoma City OK, Kansas City MO, Houston TX,
Sponsor: Travere Therapeutics, Inc.

Sex: All

Age: 1 - 17

Code: NCT05003986

Phase2, Recruiting

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

for
Recurrent Ovarian High Grade Serous Adenocarcinoma,
Location: Oklahoma City OK, Nashville TN, Rochester MN,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT04633239

Phase1, Recruiting

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Oklahoma City OK, Dallas TX, Houston TX, St Louis MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05614739

Phase1, Recruiting

Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)

for
Paroxysmal Atrial Fibrillation
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 21 - 70+

Code: NCT05172765

Recruiting

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

for
Metastatic Colorectal Carcinoma,
Location: Oklahoma City OK, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05803382

Phase1, Recruiting

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

for
Advanced Malignant Solid Neoplasm,
Location: Oklahoma City OK, Overland Park KS, Fairway KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691491

Phase1, Phase2, Recruiting

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

for
Ulcerative Colitis, Crohn's Disease
Location: Oklahoma City OK, Detroit MI, Orange CA
Sponsor: Takeda

Sex: All

Age: 2 - 17

Code: NCT06100289

Phase3, Recruiting